releasing hormone


Also found in: Dictionary, Thesaurus, Financial, Encyclopedia, Wikipedia.
Related to releasing hormone: inhibiting hormone, Luteinizing hormone releasing hormone

re·leas·ing fac·tors (RF),

1. any substance, usually of hypothalamic origin, capable of accelerating the rate of secretion of a given hormone by the anterior pituitary gland;
2. factors required in the termination phase of either RNA biosynthesis or protein biosynthesis. Synonym(s): termination factor
3. colloquial shortened form for the HMG-CoA reductase inhibitors used as antihyperlipidemic agents, whose generic names end with the suffix statin. Synonym(s): statins

releasing hormone (RH)

one of several peptides produced by the hypothalamus and secreted directly into the anterior pituitary gland via a connecting vein. Each of the releasing hormones stimulates the pituitary to secrete a specific tropic hormone. Thus corticotropic-releasing hormone stimulates the pituitary to secrete adrenocorticotropic hormone, whereas growth hormone-releasing hormone stimulates the secretion of growth hormone. Previously called releasing factor.

re·leas·ing fac·tors

(rĕ-lēs'ing fak'tŏrz)
1. Substances, usually of hypothalamic origin, capable of accelerating the rate of secretion of a given hormone by the anterior pituitary gland.
2. Factors required in the termination phase of either RNA biosynthesis or protein biosynthesis.
Synonym(s): liberins, releasing hormone.

releasing hormone

Abbreviation: RH
Any of a group of substances secreted by the hypothalamus that control or inhibit the release of various hormones. They include thyrotropin-releasing hormone, gonadotropin-releasing hormone, dopamine, growth hormone-releasing hormone, corticotropin-releasing hormone, and somatostatin. Dopamine and somatostatin act to inhibit release of the hormones they act upon.
See also: hormone
References in periodicals archive ?
Expression of gonadotrophin releasing hormone receptor I is a favorable prognostic factor in epithelial ovarian cancer.
About EP-100 EP-100, the lead candidate from Esperance's Cationic Lytic Peptide (CLYP) platform technology, is a targeted membranedisrupting peptide designed to seek and destroy cancer cells that overexpress luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.
Under the terms of the agreement, VGX will purchase all significant assets covering ADViSYS' intellectual property including plasmid expression vectors, growth hormone releasing hormone and electrokinetic delivery technology.
Other researchers are replacing the progestins in such experiments with drugs that block the action of a hormone known as gonadotropin releasing hormone, or GnRH.
ELIGARD is a gonadotropin releasing hormone (GnRH) agonist, designed to reduce the amount of testosterone in the body by reducing its production.
Growth Hormone releasing peptides have shown on its own to robustly increase IGF-1 levels, and even greater results occurred when used with Growth Hormone Releasing Hormone (GHRH) to which also stimulates the pituitary gland to produce increased natural secretion of human growth hormone.
Debiopharm is investigating the efficacy and safety of the gonadotropin releasing hormone (GnRH) agonist analog triptorelin pamoate 6-month formulation in the treatment of children suffering from central (GnRH-dependent) precocious puberty (CPP).
Elagolix inhibits gonadotropin releasing hormone (GnRH) receptors in the pituitary gland and ultimately reduces circulating sex hormone levels.
Progenta's effects on shrinking fibroids were at least equivalent to that observed in women using an approved gonadotropin releasing hormone agonist ("GnRHa"), which is the most effective drug intervention for the condition.
Without a comprehensive NCD, as requested by the Company and reflected in this draft decision memorandum, Plenaxis(R) could receive inconsistent coverage among the Medicare carriers and intermediaries who may fail to distinguish this drug, the first gonadotropin releasing hormone (GnRH) antagonist approved for the treatment of advanced prostate cancer, from luteinizing hormone releasing hormone (LHRH) agonists.
EPCE100 is designed to seek and destroy cancer cells that overCEexpress luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.